A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
for Cardiovascular Disease
Drug: AZD0780
315 locations incl. Athens
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT07000357·Phase 3·Recruiting